General Information of Drug Metabolite (DM) (ID: DM000205) |
DM Name |
Lamotrigine-5-N-glucuronide
|
|
|
|
|
|
|
|
Full List of Drug-Metabolizing Enzyme (DME) Related to This DM |
DME(s) Producing This DM through Metabolism |
DME Name |
DME ID |
Reactant |
Reaction |
Related Drug |
REF |
UDP-glucuronosyltransferase 1A3 (UGT1A3)
|
DME0041
|
| Conjugation - Glucuronidation |
Lamotrigine
|
[1] , [2] , [3] |
UDP-glucuronosyltransferase 1A4 (UGT1A4)
|
DME0048
|
| Conjugation - Glucuronidation |
Lamotrigine
|
[1] , [2] , [3] |
|
|
|
|
|
|
|
|
|
|
|
|
|
Full List of Drug(s) That Produce This DM By Metabolism |
Lamotrigine |
DR0913
|
Approved |
Bipolar disorder |
|
References |
1 |
Pharmacokinetics, toxicology and safety of lamotrigine in epilepsy Expert Opin Drug Metab Toxicol. 2006 Dec;2(6):1009-18. doi: 10.1517/17425255.2.6.1009.
|
2 |
Studies on induction of lamotrigine metabolism in transgenic UGT1 mice. Xenobiotica. 2009 Nov;39(11):826-35.
|
3 |
UDP-glucuronosyltransferase 1A4-mediated N2-glucuronidation is the major metabolic pathway of lamotrigine in chimeric NOG-TKm30 mice with humanised-livers. Xenobiotica. 2021 Oct;51(10):1146-1154. doi: 10.1080/00498254.2021.1972492.
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.